
Companies have “tremendous concern” about the financial viability of these medications, the president and CEO of the Business Group on Heal
th said.
https://www.hrdive.com/news/glp-1-coverage-for-weight-loss-could-be-in-employers-crosshairs/819350/

Companies have “tremendous concern” about the financial viability of these medications, the president and CEO of the Business Group on Heal
th said.
https://www.hrdive.com/news/glp-1-coverage-for-weight-loss-could-be-in-employers-crosshairs/819350/